Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Suarez-Almazor

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Clinical Genitourinary Cancer|May 27, 2025
Association Between Rheumatoid Arthritis, Frailty Status, and Mortality in Older Adults with Bladder CancerMaya Swaminathan, Sarah K Holt, John L Gore, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
The Journal of Rheumatology|September 10, 2009
Assessing quality of sleep in patients with rheumatoid arthritisGeorge A Wells, Tracy Li, John R Kirwan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
The Journal of Rheumatology|September 10, 2009
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9John R Kirwan, Stanton Newman, Peter S Tugwell, et al.
Rheumatology (Oxford, England)|December 23, 2024
Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease courseNoemie Chanson, Alexandre Galvagni, Manuel Ramos-Casals, et al.
Arthritis and Rheumatism|June 3, 2008
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritisKenneth G Saag, Gim Gee Teng, Nivedita M Patkar, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Clinical Genitourinary Cancer|May 27, 2025
Association Between Rheumatoid Arthritis, Frailty Status, and Mortality in Older Adults with Bladder CancerMaya Swaminathan, Sarah K Holt, John L Gore, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
The Journal of Rheumatology|September 10, 2009
Assessing quality of sleep in patients with rheumatoid arthritisGeorge A Wells, Tracy Li, John R Kirwan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Journal for Immunotherapy of Cancer|January 8, 2019
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experienceOmar Mamlouk, Umut Selamet, Shana Machado, et al.
The Journal of Rheumatology|September 10, 2009
Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9John R Kirwan, Stanton Newman, Peter S Tugwell, et al.
Rheumatology (Oxford, England)|December 23, 2024
Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease courseNoemie Chanson, Alexandre Galvagni, Manuel Ramos-Casals, et al.
Arthritis and Rheumatism|June 3, 2008
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritisKenneth G Saag, Gim Gee Teng, Nivedita M Patkar, et al.
Pageof 5